Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001193125-26-208899

Director acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
EPSTEIN ROBERT S Director 2026-05-05 Option exercise +25,000 $1.69 $42,250 36,331 D
Derivatives
EPSTEIN ROBERT S Director 2026-05-05 Option exercise · Stock Option (Right to Buy) +25,000 0 D
Loading xslF345X06/ownership.xml…